JIA CHENG: Open Payments
NPI 1801676374 · REYNOLDSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,570 in 181 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $95 · 2025 $4,570
Food & beverage: $4,558Travel & lodging: $12
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 33 | $816 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $714 |
| Axsome Therapeutics, Inc. | 21 | $528 |
| Otsuka America Pharmaceutical, Inc. | 19 | $423 |
| Janssen Pharmaceuticals, Inc | 6 | $392 |
| Teva Pharmaceuticals USA, Inc. | 15 | $370 |
| Alkermes, Inc. | 13 | $367 |
| ABBVIE INC. | 25 | $292 |
| Vanda Pharmaceuticals Inc. | 8 | $149 |
| Neurocrine BioSciences, Inc. | 4 | $148 |
Products named: COBENFY, CAPLYTA, Auvelity, REXULTI, VRAYLAR, INVEGA SUSTENNA, ARISTADA, UZEDY.
Industry payments across OH — which companies pay providers there.
